January 7-8, 2017 — San Francisco, CA
L.E.K. Managing Director Sue St. Sure will moderate the panel ‘Biotech Partnering: Strategies for Success’ with panelists: Paul Biondi, SVP; Head, BD, Bristol-Myers Squibb; Samarth Kulkarni, CBO, CRISPR; John DeYoung, VP, WWBD, Pfizer; Henry Gosebruch, EVP, Chief Strategy Officer, AbbVie; Jay Luly, CEO, Enanta.
Date/Location: January 8, 2017
Four Seasons Hotel
757 Market Street, San Francisco, MA
Time: 11:40 a.m. — 12:10 p.m.
About Sue St. Sure:
Sue St. Sure is a Managing Director and Partner, as well as the head of L.E.K. Consulting's Los Angeles office and a member of L.E.K.'s Americas Regional Management Committee. She most recently served as the West Coast Biopharmaceuticals & Life Sciences practice leader. Sue has more than 24 years’ experience assisting companies globally in corporate and business unit strategy consulting and merger and acquisition advisory support. She has worked across many biopharmaceutical, therapeutic, and technology segments and has assisted clients with issues such as strategic opportunity evaluations, product prioritization, product planning and commercialization, strategic partnering, and mergers and acquisitions. Sue has also worked across a wide range of therapeutic and technology areas.
Sue earned a Master of Business Administration from the Anderson School at the University of California, Los Angeles (UCLA) and completed graduate work in Neuroscience at the University of California, San Diego. She also received her Bachelor of Arts degree from UCLA, where she graduated Phi Beta Kappa and summa cum laude.
About Boston Biotech Conferences
The Boston Biotech Conferences (BBC) are exclusive, thought-leader forums for senior biopharma executives. Each conference is highly interactive and co-hosted by healthcare industry leaders to foster discussions and facilitate information-sharing, networking and corporate development within the biopharma community.
East/West CEO is a networking forum for industry CEOs and decision makers in the life sciences. Attendees gain insights from presentations and discussion panels featuring CEOs from several of the world's leading biopharmaceutical companies. Healthcare investors also attend.
About L.E.K. Consulting:
L.E.K. Consulting is a global management consulting firm that uses deep industry expertise and rigorous analysis to help business leaders achieve practical results with real impact. We are uncompromising in our approach to helping clients consistently make better decisions, deliver improved business performance and create greater shareholder returns. The firm advises and supports global companies that are leaders in their industries — including the largest private and public sector organizations, private equity firms and emerging entrepreneurial businesses. Founded more than 30 years ago, L.E.K. employs more than 1,200 professionals across the Americas, Asia-Pacific and Europe. For more information, go to www.lek.com.